Abstract
A series of new substituted pyrazoles 2-12 have been synthesized. The synthesized compounds are structural analogues of GGT1-DU40 1, a highly potent and selective inhibitor of protein geranylgeranyltransferase I (GGTase-I) both in vitro and in vivo. The implications of GGTase-I in oncogenesis have highlighted its potential as a cancer therapeutic target. Accordingly, the development of GGTase-I inhibitors has been a subject of much interest. The synthesis of 2-12 stemmed from the acetylation or acylation of N-function of amino acids to produce suitably modified amino acids. Meanwhile, the substituted pyrazole subunit originated from the reaction of ethyl nicotinate with γ-butyrolactone followed by condensation of the resultant β-keto lactone with (3,4-dichlorophenyl) hydrazine. The operations of O-alkylation and thioetherification on the resultant intermediate eventually produced the substituted pyrazole fragment. The amidation of the latter with amino acid derivatives finally rendered 2-12 in good to excellent yields.
Original language | English |
---|---|
Pages (from-to) | 333-344 |
Number of pages | 12 |
Journal | Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences |
Volume | 71 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2016 |
Bibliographical note
Funding Information:The financial support from National Plan for Science, Technology, and Innovation (project 11-BIO2138-04) and facilities provided by King Fahd University of Petroleum and Minerals are gratefully acknowledged.
Keywords
- GGT1-DU40
- Geranylgeranyltransferase I
- Oncogenesis
- Protein prenylation
- Pyrazole-based inhibitors
ASJC Scopus subject areas
- General Chemistry